Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Up 55.9% in November

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 4,380,000 shares, an increase of 55.9% from the October 31st total of 2,810,000 shares. Currently, 8.0% of the shares of the company are short sold. Based on an average trading volume of 985,600 shares, the days-to-cover ratio is currently 4.4 days.

Institutional Trading of Aurora Cannabis

Hedge funds and other institutional investors have recently bought and sold shares of the company. Cubist Systematic Strategies LLC bought a new stake in Aurora Cannabis during the 2nd quarter worth approximately $50,000. Cetera Advisors LLC bought a new stake in Aurora Cannabis during the 1st quarter worth approximately $59,000. Toronto Dominion Bank increased its holdings in shares of Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Baader Bank Aktiengesellschaft increased its holdings in shares of Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the last quarter. Finally, Mackenzie Financial Corp bought a new position in shares of Aurora Cannabis in the 2nd quarter worth $113,000. Institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Stock Performance

NASDAQ ACB opened at $4.54 on Friday. The company’s 50 day moving average is $5.29 and its 200-day moving average is $5.74. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The firm has a market cap of $248.97 million, a P/E ratio of -5.97 and a beta of 1.87.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.